{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:07:57Z","timestamp":1755223677320,"version":"3.43.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,11]]},"DOI":"10.7759\/cureus.89850","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:09:37Z","timestamp":1754978977000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel Interleukin-11 Inhibitors Attenuate Collagen Production in Patient-Derived Synovial Fibroblasts"],"prefix":"10.7759","author":[{"given":"Ryan","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"De Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Saweikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Chaffee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy A","family":"Swindlehurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170990","article-title":"Rates of total joint replacement in the United States: future projections to 2020-2040 using the National Inpatient Sample","volume":"46","author":"Singh JA","year":"2019","unstructured":"Singh JA, Yu S, Chen L, Cleveland JD. Rates of total joint replacement in the United States: future projections to 2020-2040 using the National Inpatient Sample. J Rheumatol. 2019, 46:1134-40. 10.3899\/jrheum.170990","journal-title":"J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2017.02.005","article-title":"Arthrofibrosis associated with total knee arthroplasty","volume":"32","author":"Cheuy VA","year":"2017","unstructured":"Cheuy VA, Foran JR, Paxton RJ, Bade MJ, Zeni JA, Stevens-Lapsley JE. Arthrofibrosis associated with total knee arthroplasty. J Arthroplasty. 2017, 32:2604-11. 10.1016\/j.arth.2017.02.005","journal-title":"J Arthroplasty"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-015-3799-x","article-title":"Procedural intervention for arthrofibrosis after ACL reconstruction: trends over two decades","volume":"25","author":"Sanders TL","year":"2017","unstructured":"Sanders TL, Kremers HM, Bryan AJ, Kremers WK, Stuart MJ, Krych AJ. Procedural intervention for arthrofibrosis after ACL reconstruction: trends over two decades. Knee Surg Sports Traumatol Arthrosc. 2017, 25:532-7. 10.1007\/s00167-015-3799-x","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.otsr.2014.06.026","article-title":"Post-traumatic knee stiffness: surgical techniques","volume":"101","author":"Pujol N","year":"2015","unstructured":"Pujol N, Boisrenoult P, Beaufils P. Post-traumatic knee stiffness: surgical techniques. Orthop Traumatol Surg Res. 2015, 101:S179-86. 10.1016\/j.otsr.2014.06.026","journal-title":"Orthop Traumatol Surg Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.19.00223","article-title":"Clinical management of arthrofibrosis: state of the art and therapeutic outlook","volume":"8","author":"Ibrahim IO","year":"2020","unstructured":"Ibrahim IO, Nazarian A, Rodriguez EK. Clinical management of arthrofibrosis: state of the art and therapeutic outlook. JBJS Rev. 2020, 8:e1900223. 10.2106\/JBJS.RVW.19.00223","journal-title":"JBJS Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-019-0047-x","article-title":"Pathological mechanisms and therapeutic outlooks for arthrofibrosis","volume":"7","author":"Usher KM","year":"2019","unstructured":"Usher KM, Zhu S, Mavropalias G, Carrino JA, Zhao J, Xu J. Pathological mechanisms and therapeutic outlooks for arthrofibrosis. Bone Res. 2019, 7:9. 10.1038\/s41413-019-0047-x","journal-title":"Bone Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200307000-00014","article-title":"Predicting range of motion after total knee arthroplasty: clustering, log-linear regression, and regression tree analysis","volume":"85","author":"Ritter MA","year":"2003","unstructured":"Ritter MA, Harty LD, Davis KE, Meding JB, Berend ME. Predicting range of motion after total knee arthroplasty: clustering, log-linear regression, and regression tree analysis. J Bone Joint Surg Am. 2003, 85:1278-85. 10.2106\/00004623-200307000-00014","journal-title":"J Bone Joint Surg Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall RT","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014, 5:123. 10.3389\/fphar.2014.00123","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(01)01863-4","article-title":"Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation","volume":"22","author":"Buckley CD","year":"2001","unstructured":"Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001, 22:199-204. 10.1016\/s1471-4906(01)01863-4","journal-title":"Trends Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Desmouli\u00e8re A","year":"1993","unstructured":"Desmouli\u00e8re A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993, 122:103-11. 10.1083\/jcb.122.1.103","journal-title":"J Cell Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis N","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020, 217:e20190103. 10.1084\/jem.20190103","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/BLO.0b013e3180312c01","article-title":"Myofibroblast upregulators are elevated in joint capsules in posttraumatic contractures","volume":"456","author":"Hildebrand KA","year":"2007","unstructured":"Hildebrand KA, Zhang M, Hart DA. Myofibroblast upregulators are elevated in joint capsules in posttraumatic contractures. Clin Orthop Relat Res. 2007, 456:85-91. 10.1097\/BLO.0b013e3180312c01","journal-title":"Clin Orthop Relat Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2010.145","article-title":"Gene delivery of TGF-\u03b21 induces arthrofibrosis and chondrometaplasia of synovium in vivo","volume":"90","author":"Watson RS","year":"2010","unstructured":"Watson RS, Gouze E, Levings PP, et al.. Gene delivery of TGF-\u03b21 induces arthrofibrosis and chondrometaplasia of synovium in vivo. Lab Invest. 2010, 90:1615-27. 10.1038\/labinvest.2010.145","journal-title":"Lab Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2018.09.002","article-title":"TGF-\u03b2 receptors: in and beyond TGF-\u03b2 signaling","volume":"52","author":"Vander Ark A","year":"2018","unstructured":"Vander Ark A, Cao J, Li X. TGF-\u03b2 receptors: in and beyond TGF-\u03b2 signaling. Cell Signal. 2018, 52:112-20. 10.1016\/j.cellsig.2018.09.002","journal-title":"Cell Signal"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn TA","year":"2004","unstructured":"Wynn TA. Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol. 2004, 4:583-94. 10.1038\/nri1412","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn TA","year":"2010","unstructured":"Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010, 30:245-57. 10.1055\/s-0030-1255354","journal-title":"Semin Liver Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer S","year":"2017","unstructured":"Schafer S, Viswanathan S, Widjaja AA, et al.. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature. 2017, 552:110-5. 10.1038\/nature24676","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104806","article-title":"IL11 stimulates ERK\/P90RSK to inhibit LKB1\/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells","volume":"25","author":"Widjaja AA","year":"2022","unstructured":"Widjaja AA, Viswanathan S, Wei Ting JG, et al.. IL11 stimulates ERK\/P90RSK to inhibit LKB1\/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells. iScience. 2022, 25:104806. 10.1016\/j.isci.2022.104806","journal-title":"iScience"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810072","article-title":"WNT\/\u03b2-catenin signaling promotes TGF-\u03b2-mediated activation of human cardiac fibroblasts by enhancing IL-11 production","volume":"22","author":"Dzia\u0142o E","year":"2021","unstructured":"Dzia\u0142o E, Czepiel M, Tkacz K, Siedlar M, Kania G, B\u0142yszczuk P. WNT\/\u03b2-catenin signaling promotes TGF-\u03b2-mediated activation of human cardiac fibroblasts by enhancing IL-11 production. Int J Mol Sci. 2021, 22:10072. 10.3390\/ijms221810072","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00531-5","article-title":"Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway","volume":"52","author":"Ng B","year":"2020","unstructured":"Ng B, Cook SA, Schafer S. Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway. Exp Mol Med. 2020, 52:1871-8. 10.1038\/s12276-020-00531-5","journal-title":"Exp Mol Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.156863","article-title":"Transforming growth factor beta induces interleukin-11 expression in osteoarthritis","volume":"187","author":"Lokau J","year":"2025","unstructured":"Lokau J, Bollmann M, Garbers Y, Feist E, Lohmann CH, Bertrand J, Garbers C. Transforming growth factor beta induces interleukin-11 expression in osteoarthritis. Cytokine. 2025, 187:156863. 10.1016\/j.cyto.2025.156863","journal-title":"Cytokine"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-017-9589-y","article-title":"IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells","volume":"21","author":"Elshabrawy HA","year":"2018","unstructured":"Elshabrawy HA, Volin MV, Essani AB, et al.. IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells. Angiogenesis. 2018, 21:215-28. 10.1007\/s10456-017-9589-y","journal-title":"Angiogenesis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/jor.25061","article-title":"Differences in synovial fibrosis relative to range of motion in knee osteoarthritis patients","volume":"40","author":"Hodgeson S","year":"2022","unstructured":"Hodgeson S, O'Brien S, Simkin J, Plakotaris E, McCarthy C, Dasa V, Marrero L. Differences in synovial fibrosis relative to range of motion in knee osteoarthritis patients. J Orthop Res. 2022, 40:584-94. 10.1002\/jor.25061","journal-title":"J Orthop Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/circ.142.suppl_3.17055","article-title":"Abstract 17055: Novel dual mTOR inhibitor\/AMPK activator mitigates Doxorubicin cardiotoxicity and potentiates its chemotherapeutic efficacy against triple negative breast cancer","volume":"142","author":"Das A","year":"2020","unstructured":"Das A, Hovsepian S, Das S, et al.. Abstract 17055: Novel dual mTOR inhibitor\/AMPK activator mitigates Doxorubicin cardiotoxicity and potentiates its chemotherapeutic efficacy against triple negative breast cancer. Circulation. 2020, 142:17055. 10.1161\/circ.142.suppl_3.17055","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2020-lb-211","article-title":"Abstract LB-211: Synergistic anti-metastatic effect of pembrolizumab in combination with a novel mTORC1 inhibitor\/AMPK agonist in a CAM metastatic triple negative breast cancer model","volume":"80","author":"Fung L","year":"2020","unstructured":"Fung L, Corral LG, Sullivan RW, Chan KW, Swindlehurst CA. Abstract LB-211: Synergistic anti-metastatic effect of pembrolizumab in combination with a novel mTORC1 inhibitor\/AMPK agonist in a CAM metastatic triple negative breast cancer model. Cancer Res. 2020, 80:211. 10.1158\/1538-7445.am2020-lb-211","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00603.2017","article-title":"A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure","volume":"315","author":"Bradley JM","year":"2018","unstructured":"Bradley JM, Spaletra P, Li Z, et al.. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure. Am J Physiol Heart Circ Physiol. 2018, 315:H563-70. 10.1152\/ajpheart.00603.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/art.38871","article-title":"Prolonged tumor necrosis factor \u03b1 primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin","volume":"67","author":"Sohn C","year":"2015","unstructured":"Sohn C, Lee A, Qiao Y, Loupasakis K, Ivashkiv LB, Kalliolias GD. Prolonged tumor necrosis factor \u03b1 primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol. 2015, 67:86-95. 10.1002\/art.38871","journal-title":"Arthritis Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s40634-023-00650-8","article-title":"Minoxidil weakens newly synthesized collagen in fibrotic synoviocytes from osteoarthritis patients","volume":"10","author":"Sarkovich S","year":"2023","unstructured":"Sarkovich S, Issa PP, Longanecker A, et al.. Minoxidil weakens newly synthesized collagen in fibrotic synoviocytes from osteoarthritis patients. J Exp Orthop. 2023, 10:84. 10.1186\/s40634-023-00650-8","journal-title":"J Exp Orthop"},{"key":"ref29","unstructured":"Marrero L. Fibrogenic stimulation (48h) of human fibroblastic synoviocytes (HFLS) for NMX treatment. Created in BioRender. (2025). Accessed: July 14, 2025: https:\/\/BioRender.com\/89a2snn."},{"key":"ref30","unstructured":"Marrero L. Isolation of patient-derived fibroblastic synovial cells (FSCs). Created in BioRender. (2025). Accessed: July 14, 2025: https:\/\/BioRender.com\/wy5d4jp."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.26058.1","article-title":"Interleukin-6 signalling in health and disease","volume":"9","author":"Rose-John S","year":"2020","unstructured":"Rose-John S. Interleukin-6 signalling in health and disease. F1000Res. 2020, 9:1013. 10.12688\/f1000research.26058.1","journal-title":"F1000Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-006-0019-9","article-title":"Interleukin-6 and its receptor: from bench to bedside","volume":"195","author":"Scheller J","year":"2006","unstructured":"Scheller J, Rose-John S. Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol. 2006, 195:173-83. 10.1007\/s00430-006-0019-9","journal-title":"Med Microbiol Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.06.017","article-title":"Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically","volume":"24","author":"Putoczki TL","year":"2013","unstructured":"Putoczki TL, Thiem S, Loving A, et al.. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell. 2013, 24:257-71. 10.1016\/j.ccr.2013.06.017","journal-title":"Cancer Cell"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29995-2","article-title":"Na\/K-ATPase Y260 phosphorylation-mediated Src regulation in control of aerobic glycolysis and tumor growth","volume":"8","author":"Banerjee M","year":"2018","unstructured":"Banerjee M, Cui X, Li Z, et al.. Na\/K-ATPase Y260 phosphorylation-mediated Src regulation in control of aerobic glycolysis and tumor growth. Sci Rep. 2018, 8:12322. 10.1038\/s41598-018-29995-2","journal-title":"Sci Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123207","article-title":"The Na\/K-ATPase \u03b11\/Src signaling axis regulates mitochondrial metabolic function and redox signaling in human iPSC-derived cardiomyocytes","volume":"11","author":"Cai L","year":"2023","unstructured":"Cai L, Pessoa MT, Gao Y, et al.. The Na\/K-ATPase \u03b11\/Src signaling axis regulates mitochondrial metabolic function and redox signaling in human iPSC-derived cardiomyocytes. Biomedicines. 2023, 11:3207. 10.3390\/biomedicines11123207","journal-title":"Biomedicines"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11613","article-title":"Attenuation of the Na\/K\u2011ATPase\/Src\/ROS amplification signaling pathway by astaxanthin ameliorates myocardial cell oxidative stress injury","volume":"22","author":"Qu X","year":"2020","unstructured":"Qu X, Zhang Z, Hu W, et al.. Attenuation of the Na\/K\u2011ATPase\/Src\/ROS amplification signaling pathway by astaxanthin ameliorates myocardial cell oxidative stress injury. Mol Med Rep. 2020, 22:5125-34. 10.3892\/mmr.2020.11613","journal-title":"Mol Med Rep"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666180110101052","article-title":"Targeting Na\/K-ATPase signaling: a new approach to control oxidative stress","volume":"24","author":"Liu J","year":"2018","unstructured":"Liu J, Lilly MN, Shapiro JI. Targeting Na\/K-ATPase signaling: a new approach to control oxidative stress. Curr Pharm Des. 2018, 24:359-64. 10.2174\/1381612824666180110101052","journal-title":"Curr Pharm Des"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00384.2010","article-title":"Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer","volume":"302","author":"Huynh TP","year":"2012","unstructured":"Huynh TP, Mah V, Sampson VB, et al.. Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. Am J Physiol Lung Cell Mol Physiol. 2012, 302:L1150-8. 10.1152\/ajplung.00384.2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1385\/cbb:46:3:303","article-title":"The Na,K-ATPase receptor complex: its organization and membership","volume":"46","author":"Pierre SV","year":"2006","unstructured":"Pierre SV, Xie Z. The Na,K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys. 2006, 46:303-16. 10.1385\/cbb:46:3:303","journal-title":"Cell Biochem Biophys"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1159\/000351179","article-title":"Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation","volume":"126","author":"Wang Y","year":"2013","unstructured":"Wang Y, Wu Y, Chen J, Zhao S, Li H. Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation. Cardiology. 2013, 126:1-11. 10.1159\/000351179","journal-title":"Cardiology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5636","article-title":"Role of STAT3 in cancer cell epithelial\u2011mesenchymal transition (Review)","volume":"64","author":"Zhang G","year":"2024","unstructured":"Zhang G, Hou S, Li S, Wang Y, Cui W. Role of STAT3 in cancer cell epithelial\u2011mesenchymal transition (Review). Int J Oncol. 2024, 64:10.3892\/ijo.2024.5636","journal-title":"Int J Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1564176","article-title":"Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis","volume":"12","author":"Zheng C","year":"2025","unstructured":"Zheng C, Zhang L, Sun Y, Ma Y, Zhang Y. Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis. Front Mol Biosci. 2025, 12:1564176. 10.3389\/fmolb.2025.1564176","journal-title":"Front Mol Biosci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0575","article-title":"Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression","volume":"67","author":"Lo HW","year":"2007","unstructured":"Lo HW, Hsu SC, Xia W, et al.. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 2007, 67:9066-76. 10.1158\/0008-5472.CAN-07-0575","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocl.2019.02.005","article-title":"Arthrofibrosis after total knee arthroplasty: pathophysiology, diagnosis, and management","volume":"50","author":"Thompson R","year":"2019","unstructured":"Thompson R, Novikov D, Cizmic Z, et al.. Arthrofibrosis after total knee arthroplasty: pathophysiology, diagnosis, and management. Orthop Clin North Am. 2019, 50:269-79. 10.1016\/j.ocl.2019.02.005","journal-title":"Orthop Clin North Am"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1080\/09593985.2017.1346027","article-title":"Presentation and management of arthrofibrosis of the knee: a case report","volume":"33","author":"Scholtes SA","year":"2017","unstructured":"Scholtes SA, Khoo-Summers L, Damico KJ. Presentation and management of arthrofibrosis of the knee: a case report. Physiother Theory Pract. 2017, 33:815-24. 10.1080\/09593985.2017.1346027","journal-title":"Physiother Theory Pract"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-184","article-title":"Arthrofibrosis after TKA: influence factors on the absolute flexion and gain in flexion after manipulation under anaesthesia","volume":"12","author":"Ipach I","year":"2011","unstructured":"Ipach I, Mittag F, Lahrmann J, Kunze B, Kluba T. Arthrofibrosis after TKA: influence factors on the absolute flexion and gain in flexion after manipulation under anaesthesia. BMC Musculoskelet Disord. 2011, 12:184. 10.1186\/1471-2474-12-184","journal-title":"BMC Musculoskelet Disord"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot095505","article-title":"Analysis of cell viability by the MTT assay","volume":"2018","author":"Kumar P","year":"2018","unstructured":"Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. 2018, 2018:10.1101\/pdb.prot095505","journal-title":"Cold Spring Harb Protoc"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.646984","article-title":"Metabolic reprogramming is required for myofibroblast contractility and differentiation","volume":"290","author":"Bernard K","year":"2015","unstructured":"Bernard K, Logsdon NJ, Ravi S, et al.. Metabolic reprogramming is required for myofibroblast contractility and differentiation. J Biol Chem. 2015, 290:25427-38. 10.1074\/jbc.M115.646984","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation","volume":"127","author":"Gibb AA","year":"2020","unstructured":"Gibb AA, Lazaropoulos MP, Elrod JW. Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circ Res. 2020, 127:427-47. 10.1161\/CIRCRESAHA.120.316958","journal-title":"Circ Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/antiox6010018","article-title":"Na\/K-ATPase signaling and salt sensitivity: the role of oxidative stress","volume":"6","author":"Liu J","year":"2017","unstructured":"Liu J, Yan Y, Nie Y, Shapiro JI. Na\/K-ATPase signaling and salt sensitivity: the role of oxidative stress. Antioxidants (Basel). 2017, 6:18. 10.3390\/antiox6010018","journal-title":"Antioxidants (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1031890","article-title":"Metabolic reprogramming of pulmonary fibrosis","volume":"13","author":"Li J","year":"2022","unstructured":"Li J, Zhai X, Sun X, Cao S, Yuan Q, Wang J. Metabolic reprogramming of pulmonary fibrosis. Front Pharmacol. 2022, 13:1031890. 10.3389\/fphar.2022.1031890","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393388-novel-interleukin-11-inhibitors-attenuate-collagen-production-in-patient-derived-synovial-fibroblasts","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:09:38Z","timestamp":1754978978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393388-novel-interleukin-11-inhibitors-attenuate-collagen-production-in-patient-derived-synovial-fibroblasts"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.89850","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}